Identification of biomarkers for cervical cancer in peripheral blood lymphocytes using oligonucleotide microarrays

Chinese Medical Journal

Volumn 123, Issue 8, 2010, Pages 1000-1005

  Sheng, Jie ^a   Zhang, Wei yuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Microarrays; Peripheral lymphocyte; Uterine cervical neoplasms

Indexed keywords

BIOLOGICAL MARKER; ENOLASE; ENOLASE 2; NUCLEOLIN; OLIGONUCLEOTIDE; PEPTIDES AND PROTEINS; POLYADENYLIC ACID BINDING PROTEIN; POLYADENYLIC ACID BINDING PROTEIN C 1; SOMATOMEDIN BINDING PROTEIN 3; TENASIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN GENOME; HUMAN TISSUE; PERIPHERAL LYMPHOCYTE; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER;

ADULT; FEMALE; HUMANS; LYMPHOCYTES; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 77951247400     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.08.005     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Stanley M. Immune responses to human papillomavirus. Vaccine 2006; 24 Suppl 1: S16-S22.
3. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120-2129.
4. Sova P, Feng QH, Geiss G, Wood T, Strauss R, Rudolf V, et al. Discovery of novel methylation biomarkers in cervicalcarcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 114-123.
5. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-470.
6. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 133: 1-5.
7. Pappa KI, Anagnou NP. Emerging issues of the expression profiling technologies for the study of gynecologic cancer. Am J Obstet Gynecol 2005; 193: 908-918.
8. Chao A, Wang TH, Lee YS, Hsueh S, Chao AS, Chang TC, et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 2006; 119: 91-98.
9. Tzouvelekis A, Patlakas G, Bouros D. Application of microarray technology in pulmonary diseases. Respir Res 2004; 5: 26.
10. Bovin LF, Rieneck K, Workman C, Nielsen H, Sørensen SF, Skjødt H, et al. Blood cell gene expression profiling in rheumatoid arthritis: discriminative genes and effect of rheumatoid factor. Immunol Lett 2004; 93: 217-226.
11. Twine NC, Stover JA, Marshall B, Dukart G, Hidalgo M, Stadler W, et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 2003; 63: 6069-6075.
12. Burczynski ME, Twine NC, Dukart G, Marshall B, Hidalgo M, Stadler WM, et al. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin Cancer Res 2005; 11: 1181-1189.
13. Martin CM, Kehoe L, Spillane CO, O'Leary JJ. Gene discovery in cervical cancer: towards diagnostic and therapeutic biomarkers. Mol Diagn Ther 2007; 11: 277-290.
14. Fujimoto T, Nishikawa A, Iwasaki M, Akutagawa N, Teramoto M, Kudo R. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array. Gynecol Oncol 2004; 93: 446-453.
15. Wong YF, Cheung TH, Tsao GS, Lo KW, Yim SF, Wang VW, et al. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 2006; 118: 2461-2469.
16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98: 5116-5121.
17. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 2003; 200: 488-499.
18. Buvukbavram H, Arslan A. Value of tenascin-C content and association with clinicopathological parameters in uterine cervical lesions. Int J Cancer 2002; 100: 719-722.
19. Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 2004; 10: 2491-2498.
20. Juuti A, Nordling S, Louhimo J, Lundin J, Haglund C. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation. J Clin Pathol 2004; 57: 1151-1155.
21. Gazzaniga P, Nofroni I, Gandini O, Silvestri I, Frati L, Aglianò AM, et al. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer. Oncol Rep 2005; 14: 1199-1202.
22. Zou W. Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat Rev Cancer 2005; 5: 263-274.
23. Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, Knoll C, et al. Beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 2005; 24: 8200-8204.
24. Aishima S, Taguchi K, Terashi T, Matsuura S, Shimada M, Tsuneyoshi M. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol 2003; 16: 1019-1027.
25. Atula T, Hedström J, Finne P, Leivo I, Markkanen-Leppänen M, Haglund C. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res 2003; 23: 3051-3056.
26. Gladson CL. Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 1996; 55: 1143-1149.
27. Derenzini M, Sirri V, Trerè D, Ochs RS. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995; 73: 497-502.
28. Storck S, Shukla M, Dimitrov S, Bouvet P. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 2007; 41: 125-144.
29. Grinstein E, Shan Y, Karawajew L, Snijders PJ, Meijer CJ, Royer HD, et al. Cell Cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation. J Biol Chem 2006; 281: 22223-22235.
30. Ridlev L, Rahman R, Brundler MA, Ellison D, Lowe J, Robson K, et al. Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol 2008; 13: 675-689.
31. Chekhonin VP, Zhirkov YA, Belyaeva IA, Ryabukhin IA, Gurina OI, Dmitriyeva TB. Serum time course of two brain-specific proteins, alpha(1) brain globulin and neuron-specific enolase, in tick-born encephalitis and Lyme disease. Clin Chim Acta 2002; 320: 117-125.
32. Kasprzak A, Zabel M, Biczysko W. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours. Pol J Pathol 2007; 58: 23-33.
33. Nakatsuka S, Nishiu M, Tomita Y, Miwa H, Takakuwa T, Iuchi K, et al. Enhanced expression of neuron-specific enolase (NSE) in pyothorax-associated lymphoma (PAL). Cancer Res Apr 2002; 93: 411-416.
34. Stern P, Bartos V, Uhrova J, Bezdickova D, Vanickova Z, Tichy V, et al. Performance characteristics of seven neuron-specific enolase assays. Tumour Biol 2007; 28: 84-92.